GlassScriptPhysician profile
Priyanka Sood
NPI 1538346093
$12,760.79
in general payments reported to CMS, 2019-2025
17 companies · $2,577 in 2025
The $2,577 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,196 · 2020: $3,037 · 2021: $170 · 2022: $2,266 · 2023: $3,500 · 2024: $14.99 · 2025: $2,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $592.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $3,124.90 | 2020-2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $2,986.00 | 2019-2024 | Veracity Surgical, Quatera 700, Visumax |
| Harrow Eye, LLC | $2,046.98 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $1,762.54 | 2019-2021 | |
| Shire North American Group INC | $700.00 | 2019 | |
| Abbvie INC. | $693.78 | 2023-2025 | Alphagan P, Vuity, Lumigan |
| Eyepoint US, INC. | $289.04 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $268.93 | 2022-2025 | Veracity Surgical |
| Johnson & Johnson Surgical Vision, INC. | $190.66 | 2025 | Tecnis Iol, Tecnis Simplicity |
| Kala Pharmaceuticals, INC. | $189.24 | 2019-2021 | |
| Oyster Point Pharma, INC. | $148.28 | 2022 | |
| Rxsight INC | $124.95 | 2022 | |
| Alcon Vision LLC | $80.42 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $56.37 | 2025 | Xdemvy |
| Quidel Corporation | $44.24 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $38.50 | 2019 | |
| Eyevance Pharmaceuticals LLC | $15.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.